Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/NEUREN-PHARMACEUTICALS-LI-10354053/nieuws/Neuren-Pharmaceuticals-Limited-begint-Fase-2-proeven-met-NNZ-2591-in-PMS-en-PTHS-41236944/?utm_source=whatsapp&utm_medium=social&utm_campaign=share